JPIVX
Price
$30.06
Change
+$0.34 (+1.14%)
Updated
Dec 20 closing price
RMFEX
Price
$55.06
Change
+$0.56 (+1.03%)
Updated
Dec 20 closing price
Ad is loading...

JPIVX vs RMFEX

Header iconJPIVX vs RMFEX Comparison
Open Charts JPIVX vs RMFEXBanner chart's image
JPMorgan U.S. Applied Data Sci Val I
Price$30.06
Change+$0.34 (+1.14%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R4
Price$55.06
Change+$0.56 (+1.03%)
VolumeN/A
CapitalizationN/A
JPIVX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPIVX vs. RMFEX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPIVX is a Sell and RMFEX is a Buy.

FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 102B vs. JPIVX (167M). RMFEX pays higher dividends than JPIVX: RMFEX (1.95) vs JPIVX (1.65). JPIVX was incepted earlier than RMFEX: JPIVX (22 years) vs RMFEX (23 years). RMFEX is a more actively managed with annual turnover of: 25.00 vs. JPIVX (17.00). RMFEX has a lower initial minimum investment than JPIVX: RMFEX (250) vs JPIVX (1000000). RMFEX annual gain was more profitable for investors over the last year : 11.46 vs. JPIVX (9.94). RMFEX return over 5 years is better than : 39.98 vs. JPIVX (4.38).
JPIVXRMFEXJPIVX / RMFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD8.88610.27986%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets167M102B0%
Annual Yield % from dividends1.651.9585%
Returns for 1 year9.9411.4687%
Returns for 3 years4.9513.4337%
Returns for 5 years4.3839.9811%
Returns for 10 years-4.3965.36-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEVO1.520.06
+4.11%
Gevo
RLMD0.360.01
+2.89%
Relmada Therapeutics
KARO46.800.80
+1.74%
Karooooo Ltd
AMED84.470.69
+0.82%
Amedisys
ALB88.65-0.27
-0.30%
Albemarle Corp